In this case-based discussion, Dr. David Chin Yee presents his challenges and outcomes when managing a patient with diabetic macular edema who initially declined treatment due to language limitations, cultural beliefs, and mistrust of medical interventions. The case highlights the implementation of culturally sensitive strategies and underscores the value of cultural competence and patient-centered communication in overcoming barriers to care.
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

Transcript
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
closeTranscript
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
closeTranscript
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
closeAnnouncer:
Welcome to CE on ReachMD. This activity, titled “Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease” is provided by Evolve Medical Education.
Prior to beginning the activity, please be sure to review the faculty and commercial support disclosure statements as well as the learning objectives.
Dr. Chin Yee:
Hi, I'm David Chin Yee from Georgia Retina in Atlanta, Georgia, and I'm here to share a patient case study overcoming cultural and communication barriers in diabetic macular edema management.
So in this case scenario here, we have a diabetic patient of mine, Mrs. Maria Gonzalez, who is 58 years old. Her background, she's Mexican-American, first-generation immigrant, and her primary language is Spanish. She does have some limited English proficiency, where she could communicate socially, but in terms of a medical background, that can be quite challenging.
Her occupation, she's a housekeeper by trade, and giving her medical history, she notes that she has had type 2 diabetes for the past potentially 12 years. And of note, currently, her sugar control, her hemoglobin A1c was 9.8% at presentation. She also reported no prior eye exam in the past 5+ years and a strong family history of diabetes and diabetic retinopathy.
So when she presented, she was presented and referred by a family friend, and her main issue was saying, “Hey, Doc, I'm seeing blurry in the middle, especially when I'm reading or sewing.” And it started approximately 6 months ago, and truthfully, she thought it would go away. And we may hear this very commonly in many of our patients, especially in those that don't have a great understanding on the impact that diabetes can have on the eyes.
So on clinical findings, her best-corrected visual acuity in her right eye was 20/80, and then the left eye was 20/100. And we have OCT, or optical coherence tomography, pictures here, which showed bilateral center-involved diabetic macular edema. Specifically, you can see there's intraretinal fluid and hard exudates in both eyes. The central subfoveal thickness in the right eye was noted to be 485 microns, and the left eye was slightly thicker at 512 microns.
Now, we may pause here and kind of take a minute to understand when we're describing and evaluating a patient, there are some barriers. And she already is presenting some hesitation, primarily because she notes that, hey, she only speaks minimal English and she doesn't fully understand the communication or what I'm trying to get across to her. And unfortunately, presently, the clinical materials and consent forms are primarily in English only, and we did not have that available to the patient. That in and of itself can bring upon pause and hesitation for the patient to want to proceed.
In addition, she strongly noted that she really believes in folk healing or that this could get healed on its own, and she did not like the idea of having needles in the eye and had this distrust of, hey, these injections probably would hurt, potentially lead to more issues, especially growing up as a child, she was always told never stick a needle or put anything into the eye.
So based on these barriers and these hesitations she already had built in innately, you can understand where this patient, similar to many of our other patients, may not want to proceed with treatment, tagging on to the fact again that she had low understanding of how diabetes or her uncontrolled sugar could lead to eye complications and why she was having difficulty with reading and sewing, which is something she loved to do.
She also mentioned that she's had fear of prior exposure to seeing a medical doctor where cost was an issue, where she couldn't continue treatment or medication because she couldn't afford it, and as such, she had no regular primary care follow-up.
So let's take a further dive in what was then recommended. So when I first saw her, my initial treatment plan was rejected. What I recommended, which I believe many of us would do, would recommend intravitreal anti-VEGF therapy in this patient and wanted her to focus on controlling her sugars or glycemic optimization as well as possible and refer to primary care to kind of closely monitor and guide how her diabetes can not only affect her eyes but her kidneys, her actually legs, in terms of leading to neuropathy, and wanting to kind of start that conversation and start a connection for her to be able to get that under better control.
But quickly we were faced with a response, “No, Doctor, my cousin said the shots make you blind, and I'd rather use té de nopal,” which is a tea, natural tea, “and prayer. God will heal me.”
So the outcome of this challenging situation. Unfortunately, Maria declined treatment, and she did not follow up as we wanted and tried. At this point, when she said, “No injections,” the idea was to say, “All right, let me at least follow you. Would you mind coming back? Let's take a look, see how things are progressing.” And the hope was she would realize as I showed her pictures, and maybe as her vision started to get worse, we could build trust, and potentially one of my staff members who speaks Spanish could be able to explain things a little bit better.
But what we did is sit there and take a look back at how we could improve. What are some things we could do to intervene and build trust and communication in this patient? And so what we did was make sure we do have staff at other offices. Specifically, I have a care coordinator, her name is Lucia, that can be present at her follow-up or visit and would be able to be assigned that day to assist in Spanish-speaking medical consultation, describing the case and procedure and what we would be looking to do moving forward.
In addition, I was able to find Spanish pamphlets illustrating her disease and diabetes and how injections were similar to insulin for the eyes, to be able to help control how insulin is used to control sugars in the body, and how these injections in the eye would therefore be tailored towards treating the problem and therefore improving vision and sight, which is the main purpose of the eyes. So again, culturally tailored education.
We also wanted to reach out and see if there's someone in the community that could be able to form a strong connection outside of the office clinic. And we were able to find that in a community health worker who works actually at the church that she attended. And Maria was able to connect with this individual to provide assistance in transportation and also explanation, deeper dive, in explaining how best she can control her diabetes.
It was also very important that we get family involvement. Her daughter, who thankfully was more bilingual, was able to then come to additional appointments after reaching out and saying, “Please, it's very important for your mother to come in and for me to be able to explain what's going on with Mrs. Gonzalez.”
And then taking the time for empathetic listening. If we validate the beliefs that completely understand teas, these are actual diet, exercise, natural remedies, completely can be a benefit and an aid, and there's no problems in kind of going along with that. And it's validating their belief that we respect their faith and their treatment but also believing in my options to be able to work alongside and partner to be able to get good outcomes and improvement.
Now, I’ve got to be honest. The patient did not come from me calling and making these changes. There was a key turning point in her care where Maria actually returned after realizing her vision worsened while driving, and she says, “Hey, Doc, you know, I almost hit a child. I'm scared. Will you help me, even if I don't understand everything?” Now, at this time point, I was able to bring in Lucia. I was able to provide the pamphlets and educational material. I was able to have her daughter present to make sure that any concerns and fears were addressed and also provide that empathetic listening, saying, “Hey, continue doing what you're doing and working with your promotora at your church and working with taking your teas, but also continuing treatment in my office and care.”
So with this modified approach, we were able to perform her first injection with her daughter present. As I mentioned, my technician, Lucia, translated step by step what we were going to do and enlisted a post-injection call, also in Spanish, within 24 hours to address any concerns that she may have.
Transportation, she was reporting that this would be a problem moving forward and that it was hard for her daughter to come every time. But this was again arranged through a church van who provides services, because we're not far from the church, to be able to get her into the office to get treatment.
We can see her on follow-up after her first injection. Her right eye vision improved to 20/70 and left eye to 20/80, an improvement in the central thickness to 410 microns in the right eye and 435 microns in the left eye.
Long-term follow-up, thankfully, with these implementations and building confidence, we were able to continue treatment. Six months out, we can see here she had continued improvement with her vision to 20/50 and 20/60. Her central subfoveal thickness was 320 and 340. She continued with injection. She continues to drink tea, specifically tea manzanilla, which is apple tea, to help to calm her nerves, which she said again—after she had the first experience, noted the improvement and noted that, hey, there was no complications. She's continuing to do well and improve with her vision. This helped to build the confidence to continue with treatment.
Following out 12 months, she improved to 20/40, 20/50 in the left, continued resolution in terms of the CST, 295 microns, 310 microns. We were able to space the injections where she's not coming as often. She joined a diabetes support group to kind of help to continue that battle in maintaining control of her diabetes.
It was nice to see at our 18-month follow-up, she had 20/30 in the right eye, 20/40, 270 microns in the right eye, 285 microns in the left eye, and her A1c improved now to 7.4%. Not only that, she now refers her sister for screening, showing that she believes in the confidence in what we're doing in her care.
Two years out, she's 20/25 and 20/30. Good, maintained resolution of CST at 255 in the right eye, and 265 microns in the left eye, with full resolution of her macular edema. And she's getting injections roughly every 12 weeks.
So we can see the final outcome. Following up, her visual acuity is 20/25 in the right, 20/30 in the left. There's no edema on these OCTs. The retinal architecture remains stable and completely resolved. And what we'd want to see in all our patients with diabetes.
The patient testimony was in Spanish but translated. She said, “You know, at first I was afraid of the doctor and the needle, but Lucia spoke to me like family. She explained everything with pictures, and my daughter helped. Now I can see my grandchildren's faces clearly. I tell everyone at church, ‘Don't wait like I did.’”
So to summarize, I think things we need to kind of review is there are some key success factors. And it was very important for us to implement language-concordant care, whether that be in pamphlets, whether that be in staff members that could be able to communicate more clearly and allay any fears and concerns, and made that connection that is so important between a patient and their care provider.
Also having cultural humility and validation of the patient's beliefs by displaying empathy, analyzing and saying, “Hey, some of these things that you're doing will probably work, but not only that. We need assistance from us to be able to get you where we want in the end. And this partnership between us would be able to get you to be able to read, continue sewing, and achieve success in terms of your activities of daily living.”
We also enlisted the community partnership with her church and her promotora, which not only helped with her eye care but also her overall diabetic care. And you can see from the results with her A1c being a lot lower.
So implementing some of these factors can make a big difference in a patient, as in our case: family engagement, bringing the daughter in, making sure that they're also understanding, to be another listening ear, and also kind of reinforcing some of the things that we've said. Some things can be missed at the office visit, but the family being present can also help to reinforce and repeat and clarify any issues and/or concerns.
Being persistent and having follow-up, and this was also enabled in that follow-up phone call and showing true care and passion for the patient, making sure the patient understands we do understand the concerns, fears, and wanting to take the step to meet you halfway to get you to the results that we need for you to be able to be seeing better.
So just some clinical pearls. We do know that diabetic macular edema treatment adherence improves >70% when there are bilingual navigators. We also know that validating cultural practices have been shown to reduce no-show rates, similar in this patient, as well as long-term trust; you’ll sustain glycemic and visual gains.
Again, there's nothing better than being able to develop a bond with the patient, developing confidence and trust to be able to obtain better outcomes for our patients. And this was a nice case example which demonstrated how communication and understanding can help to allay some of these barriers that we and many of our patients are faced with on a day-to-day basis.
Thank you so much for your time.
Announcer:
You have been listening to CE on ReachMD. This activity is provided by Evolve Medical Education.
To receive your free CE credit, or to download this activity, go to ReachMD.com/CME. Thank you for listening.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve Medical Education, LLC (Evolve) that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve Medical Education, LLC (Evolve) has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.Faculty:
David Chin Yee, MD, FASRS
Physician Partner
Director of Clinical Research
Georgia Retina
Atlanta, GA
Dr. Chin Yee has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Advisor/Consultant: Apellis, Astellas, Eyepoint, Genentech, Regeneron
Speakers Bureau: Alcon, Ani pharmaceuticals, Apellis, Astellas, Genentech, Regeneron
Reviewers/Content Planners/Authors:- Cindy Davidson has no relevant relationships to disclose.
- Erika Langsfeld, PhD, has no relevant relationships to disclose.
- Daniel J. Olson, MD, has no relevant relationships to disclose.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Develop cultural competency and improve communication skills to address patient concerns and decisions in retinal disease care
Target Audience
This activity has been designed to meet the educational needs of optometrists, Ophthalmologists and Retina Specialists as well as all other physicians, physician assistants, nurse practitioners, nurses, and healthcare providers involved in managing patients with Retinal Disease.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this asynchronous activity for a maximum of 0.25 COPE credit hours.
Course #: 102567-TD
Activity #: 132211Provider(s)/Educational Partner(s)

Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.Commercial Support
This activity is supported by an independent educational grant from Genentech, Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
videoPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Show more
videoA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Show more
videoIt Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Show more
Focused Sight Digital Workbook
Show more
Overview
In this case-based discussion, Dr. David Chin Yee presents his challenges and outcomes when managing a patient with diabetic macular edema who initially declined treatment due to language limitations, cultural beliefs, and mistrust of medical interventions. The case highlights the implementation of culturally sensitive strategies and underscores the value of cultural competence and patient-centered communication in overcoming barriers to care.
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of Evolve Medical Education, LLC (Evolve) that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve Medical Education, LLC (Evolve) has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.Faculty:
David Chin Yee, MD, FASRS
Physician Partner
Director of Clinical Research
Georgia Retina
Atlanta, GA
Dr. Chin Yee has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Advisor/Consultant: Apellis, Astellas, Eyepoint, Genentech, Regeneron
Speakers Bureau: Alcon, Ani pharmaceuticals, Apellis, Astellas, Genentech, Regeneron
Reviewers/Content Planners/Authors:- Cindy Davidson has no relevant relationships to disclose.
- Erika Langsfeld, PhD, has no relevant relationships to disclose.
- Daniel J. Olson, MD, has no relevant relationships to disclose.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Develop cultural competency and improve communication skills to address patient concerns and decisions in retinal disease care
Target Audience
This activity has been designed to meet the educational needs of optometrists, Ophthalmologists and Retina Specialists as well as all other physicians, physician assistants, nurse practitioners, nurses, and healthcare providers involved in managing patients with Retinal Disease.
Accreditation and Credit Designation Statements
In support of improving patient care, Global Learning Collaborative (GLC) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Global Learning Collaborative (GLC) designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Global Learning Collaborative (GLC) designates this asynchronous activity for a maximum of 0.25 COPE credit hours.
Course #: 102567-TD
Activity #: 132211Provider(s)/Educational Partner(s)

Evolve Medical Education LLC (Evolve) is a leader in cultivating health care for patients by educating clinical competence of the health care team. Evolve achieves this by developing and distributing high-quality, evidence-based, valid, independent CME/CE activities in a variety of learning formats. These activities are designed to increase clinician’s knowledge, skills, competence and professional performance as well as to promote professional growth, maintenance of licensure, and support quality change in care of patients.Commercial Support
This activity is supported by an independent educational grant from Genentech, Inc.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date:
Expiration Date:
videoPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Show more
videoA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Show more
videoIt Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Show more
Focused Sight Digital Workbook
Show more
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?




